In Response to VC Funding Drought, AnVil Closes Shop, MolecularWare Finds a Buyer | GenomeWeb

Two and a half years after raising its first round of venture capital funding, informatics firm AnVil has shut its doors and is seeking a buyer for its technology, BioInform has learned. The company had been looking for an additional round of financing, but was unable to close a deal before its initial $3.5 million round ran dry, according to company officials.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.